CN1887335A - Tumor-inhibiting anticancer oral liquid - Google Patents

Tumor-inhibiting anticancer oral liquid Download PDF

Info

Publication number
CN1887335A
CN1887335A CN 200510079718 CN200510079718A CN1887335A CN 1887335 A CN1887335 A CN 1887335A CN 200510079718 CN200510079718 CN 200510079718 CN 200510079718 A CN200510079718 A CN 200510079718A CN 1887335 A CN1887335 A CN 1887335A
Authority
CN
China
Prior art keywords
grams
tumor
oral liquid
inhibiting anticancer
anticancer oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510079718
Other languages
Chinese (zh)
Other versions
CN100421708C (en
Inventor
常士杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100797185A priority Critical patent/CN100421708C/en
Publication of CN1887335A publication Critical patent/CN1887335A/en
Application granted granted Critical
Publication of CN100421708C publication Critical patent/CN100421708C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The tumor-inhibiting anticancer oral liquid is one kind of Chinese medicine preparation capable of being used in treating several kinds of tumors. The tumor-inhibiting anticancer oral liquid has the functions of supporting healthy energy to eliminate evils, promoting blood circulation to disperse blood clots, invigorating Qi, dispersing obstruction and clearing away heat and toxic material, increasing erythrocyte and platelet, raising immunity, etc. It is prepared with manyprickle acanthopanax root, glossy ganoderma, hairy vein agrimony, gynostemma pentaphylla, asparagus and other ten kinds of Chinese medicinal materials, and through soaking, thrice decoction, concentrating decoction, bottling and sterilizing.

Description

Tumor-inhibiting anticancer oral liquid
The present invention is the extract oral liquid formulation of treatment tumor.The clinical preparation title of continuing to use is " dispersing tumor protects health liquid " before applying for a patent, for the inventor in long-term clinical research and practice, the repeated screening natural Chinese medicine is through adding the effectively logical side that simplifies the treatment kinds of tumors of cutting out and decideing.
Tumor be human immunity mechanism not normal or be damaged after, a certain portion of tissue cell long-period can not homergy and the abnormal cell tissue that generates, the traditional Chinese medical science is referred to as goiter or cancerous protuberance, medically is divided into optimum and pernicious two classes.The malignant tumor serious threat mankind's life, modern medicine are generally taked operation and chemicotherapy method, but most effect is undesirable, so still be called as " incurable disease " so far.The traditional Chinese medical science thinks that tumor pathogenesis mainly is vital QI being weakened and pathogen being violent, qi stagnation blood stasis, thereby clinically rule of treatment of taking strengthening vital QI to eliminate pathogenic factors, inrigorating qi and promoting blood circulation, change silt eliminating stagnation, heat-clearing and toxic substances removing more, training revisal gas in sending an expedition against mediation, in tumor-inhibiting anticancer, transfer self resist ability, to postoperative and put, chemotherapy cancer patient, be conceived to raise red white corpuscle and platelet improve immunologic function, reduce the rate of transform and relapse rate, prolong life and improve life quality.
The present invention is with reference to the theory of anticancer medicine of modern times, follow Chinese medicine and press down cancer dispersing tumor principle, adopt natural Chinese medicine prescription compatibility, by the clinical verification of the multiple cancer of example surplus 1000, through adjusting repeatedly, it is write out a prescription substantially and is defined as: Radix Et Caulis Acanthopanacis Senticosi 1000 grams, Ganoderma 800 grams, Herba Agrimoniae 800 grams, Herb Gynostemmae Pentaphylli 800 grams, Germinatus Phragmitis 800 grams, the Radix Astragali 800 grams, Herba Solani Lyrati 800 grams, Rhizoma Smilacis Glabrae 700 grams, Semen Coicis 700 grams, Fructus Lycii 600 grams, Fructus Fici 600 grams, Pumex 600 grams, Radix Bupleuri 600 grams, the Rhizoma Pinelliae 600 grams, Rhizoma Chuanxiong 500 grams.This prescription is characterised in that the medicine of respectively distinguishing the flavor of all embodies anticancer property of medicine pharmacology from different aspects, and by the ingenious compatibility of monarch, play the effect for the treatment of both the principal and secondary aspects of a disease altogether, it is excellent to hold concurrently with the medicine food especially, and the toxicity of not having is its novel unique distinction.
Selected authentic medicinal herbs is chosen clean, cleaning, weighing, and the gauze bag of packing into is put into and decocted container, soaked 1-2 hour, heated and boiled three times is 1.5 hours for the first time, is 1 hour for the second time, be 0.5 hour for the third time, drain medicinal liquid respectively, merge three times decocting liquid, be concentrated into 10000 milliliters (relative concentration is not less than 1.02), leave standstill, filter, packing, is sealed by 10 milliliters every bottle, circulation steam sterilization 30 seconds, labeling, packing is the finished product oral liquid.
Each oral 2 bottles promptly 20 milliliters, obey every day three times, 1 bottle 10 milliliters of the every clothes of child below 10 years old, day clothes 3 times, one month is a course of treatment, general check three courses of treatment.
Period in a medicine diet Equus caballus (L.), pig head meat, sow meat, Carnis Canitis and alepidote, ban on opium-smoking and the opium trade wine and maror.

Claims (1)

1. tumor-inhibiting anticancer oral liquid for treating the Chinese medicine preparation of kinds of tumors, is characterized in that being made by following component: Radix Et Caulis Acanthopanacis Senticosi 1000 grams, Ganoderma 800 grams, Herba Agrimoniae 800 grams, Herb Gynostemmae Pentaphylli 800 grams, Germinatus Phragmitis 800 grams, the Radix Astragali 800 grams, Herba Solani Lyrati 800 grams, Rhizoma Smilacis Glabrae 700 grams, Semen Coicis 700 grams, Fructus Lycii 600 grams, Fructus Fici 600 grams, Pumex 600 grams, Radix Bupleuri 600 grams, the Rhizoma Pinelliae 600 grams, Rhizoma Chuanxiong 500 grams.
CNB2005100797185A 2005-06-27 2005-06-27 Tumor-inhibiting anticancer oral liquid Expired - Fee Related CN100421708C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100797185A CN100421708C (en) 2005-06-27 2005-06-27 Tumor-inhibiting anticancer oral liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100797185A CN100421708C (en) 2005-06-27 2005-06-27 Tumor-inhibiting anticancer oral liquid

Publications (2)

Publication Number Publication Date
CN1887335A true CN1887335A (en) 2007-01-03
CN100421708C CN100421708C (en) 2008-10-01

Family

ID=37576616

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100797185A Expired - Fee Related CN100421708C (en) 2005-06-27 2005-06-27 Tumor-inhibiting anticancer oral liquid

Country Status (1)

Country Link
CN (1) CN100421708C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773625A (en) * 2010-03-03 2010-07-14 南京中医药大学 Anticancerogen, preparation method and application thereof
CN102579916A (en) * 2012-03-16 2012-07-18 范冬锁 Capsules for treating respiratory tract and digestive tract cancers and preparation method thereof
CN103495088A (en) * 2013-10-18 2014-01-08 成都中医药大学 Medicine composition treating or adjunctively treating prostate cancer and preparation method and application thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773625A (en) * 2010-03-03 2010-07-14 南京中医药大学 Anticancerogen, preparation method and application thereof
CN101773625B (en) * 2010-03-03 2012-02-15 南京中医药大学 Anticancerogen, preparation method and application thereof
CN102579916A (en) * 2012-03-16 2012-07-18 范冬锁 Capsules for treating respiratory tract and digestive tract cancers and preparation method thereof
CN103495088A (en) * 2013-10-18 2014-01-08 成都中医药大学 Medicine composition treating or adjunctively treating prostate cancer and preparation method and application thereof
CN103495088B (en) * 2013-10-18 2015-09-30 成都中医药大学 Pharmaceutical composition of a kind for the treatment of or auxiliary treatment carcinoma of prostate and its production and use

Also Published As

Publication number Publication date
CN100421708C (en) 2008-10-01

Similar Documents

Publication Publication Date Title
CN102090696B (en) Life-nourishing health-care drink
CN101554196A (en) Natural thirsty-removing hypoglycemic tea and processing method thereof
CN1208606A (en) Face-care prepn. contg. natural ingredients
CN101124932A (en) Decoction preparation for treating viral hepatitis associated with fatty liver diseases
CN102614442B (en) Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis
CN101954028A (en) Medicinal pillow for preventing and treating myopic eyes
CN100421708C (en) Tumor-inhibiting anticancer oral liquid
CN1085441A (en) The lengthen one's life manufacture method of tea of Chinese herbal medicine detoxifcation
CN103549067A (en) Health-care tea
CN100566604C (en) A kind of nutrient health-care beverage and preparation method thereof
CN101991836B (en) Medicinal tea of short-stalk acanthopanax stem-bark for tonifying qi, tonifying blood, activating blood and removing stasis
CN101129852A (en) Oral liquid for regulating qi and tranquilizing mind
CN102920807A (en) Herb tea for lowering blood pressure
CN101940680A (en) Chinese herbal medicine for treating acute diarrhea
CN102247539A (en) Chinese medicinal health care wine
CN1232691A (en) Kidney invigorating and loins strengthening oral liquid
KR100839977B1 (en) Producing method of drinking water using oriental medicine
CN101985006A (en) Traditional Chinese herbal medicine for treating vaginal discharge diseases
CN101085259A (en) Traditional Chinese medicine decoction for treating chronic nephritis
CN1256971C (en) Capsule for curing tumor and its preparing method
CN101611872A (en) Heat-removing health tea for old people
CN1267143C (en) Method for preparing compound medicinal capsule and powder for nourishing yin
CN102430016B (en) Chinese medicinal composition for treating edema
CN101985005A (en) Chinese medicinal herb for treating abnormal menstruation
CN106551045A (en) A kind of American ginseng health tea and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20081001

Termination date: 20180627